However, depletion of both T cell subsets completely abrogated the immunogenicity of N2A-IL-2+IL-12 cells, suggesting a tumour rejection mechanism involving CD8+ T-cell activation by CD4+ T cells. This evidence concerns the gene IL2 and neoplasm.